Good morning folks,
Not every trade we make will be perfect. They won't all be winners, they won't all work out exactly as planned. There will likely always be something that we could have done better. A better entry, better risk reward, better position sizing, better exit, better timing, .... the list goes on and on. Don't look for the perfect trade>>>instead learn from every trade you make and ask yourself how you could have made it better.
Yesterday was a choppy day as we consolidate a bit after the nice run we have had. The Fed meeting begins today with the statement coming out tomorrow and we get some big earnings after the close that could impact our immediate market direction.
Gold and Oil both took a hit yesterday as the dollar strengthens that is typically bad for commodities. Keep an eye on the UUP if you are looking to trade in the commodity sectors.
IWM SMH both hit the pause button yesterday and we should expect some more choppy action until we get through the Fed statement in my opinion. Surprisingly the IBB held up fairly well yesterday.
Be patient, and always remember that cash is a viable trading position> you don't have to trade if you can't find the ideal set up and ideal entry for your style of trading.
Bullish and may have a swing or lottos in play
Cautiously optimistic
Very Cautious may even present a short opportunity .
Alibaba +11% Premarket Following Q2 Earnings Beat
| ||
06:53:57am
10/27/15 |
Yahoo Shares Up ~4.8% In Pre-Market Trading Following Alibaba Earnings Release
|
GSK's candidate Shingles Vaccine Containing Agenus' QS-21 Stimulon Shows 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in
|
Could have found a bottom on the daily does have a bear flag as well but could set up for a day trade decent short position and they have plenty of cash for the near term Looking for a 5 roll with conviction maybe even a six tag
Yandex Reports Q3 RUB$13.28 Vs Est RUB$10.12
|
Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failu
|
6:01 am Bio Blast Pharma announces positive interim results from a Phase 2 clinical study of Cabaletta, to treat oculopharyngeal muscular dystrophy (
getting a little action premarket super tiny float could test the 6 dolla holla likely going to have to raise capital soon
getting a little action premarket super tiny float could test the 6 dolla holla likely going to have to raise capital soon
UPDATE: UQM Technologies Signs Ten Year Supply Agreement with Chinese Customer, Revenues From Contract Could Exceed $400M
|
Earnings already behind this one continues to hold the 5 range after the gap up could set up for intraday play nice accumulation last few days
Trovagene's Urine-Based Liquid Biopsy Platform Shows Clinical Sensitivity of 93 Percent in Lung Cancer Study
|


No comments:
Post a Comment